Matthew Sheerin
Stock Analyst at Needham
(3.85)
# 629
Out of 5,162 analysts
156
Total ratings
68.24%
Success rate
31.45%
Average return
Main Sectors:
Stocks Rated by Matthew Sheerin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 | $21.68 | +38.38% | 2 | Apr 10, 2025 | |
| CLS Celestica | Maintains: Buy | $140 → $150 | $263.46 | -43.07% | 13 | Feb 19, 2025 | |
| EVH Evolent Health | Initiates: Buy | $15 | $2.99 | +401.67% | 1 | Jan 10, 2025 | |
| AGL agilon health | Reiterates: Hold | n/a | $0.60 | - | 1 | Jan 10, 2025 | |
| JBL Jabil | Reiterates: Buy | $150 → $160 | $250.65 | -36.17% | 14 | Dec 19, 2024 | |
| PLXS Plexus | Maintains: Hold | $136 → $150 | $190.74 | -21.36% | 2 | Dec 10, 2024 | |
| FLEX Flex Ltd. | Maintains: Buy | $40 → $48 | $63.45 | -24.34% | 8 | Dec 10, 2024 | |
| HPE Hewlett Packard Enterprise Company | Maintains: Buy | $22 → $25 | $21.58 | +15.85% | 4 | Dec 6, 2024 | |
| PSTG Everpure | Maintains: Hold | $60 → $65 | $61.50 | +5.69% | 13 | Dec 4, 2024 | |
| NTAP NetApp | Maintains: Buy | $140 → $145 | $98.66 | +46.97% | 15 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $21.46 | +30.48% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $43 → $38 | $34.27 | +10.88% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $280 | $326.18 | -14.16% | 8 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $2.5 | $2.08 | +20.19% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $50 → $55 | $59.73 | -7.92% | 10 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $90.64 | -73.52% | 3 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $260 | $116.16 | +123.83% | 6 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.50 | +3,500.72% | 1 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $112 → $66 | $133.92 | -50.72% | 8 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $80 → $90 | $75.68 | +18.92% | 7 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.23 | +45.10% | 7 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $145 | $199.41 | -27.29% | 2 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $120 | $153.14 | -21.64% | 3 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $315 | $472.16 | -33.29% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $150 | $80.86 | +85.51% | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $130 → $105 | $140.44 | -25.23% | 11 | Oct 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $20 | $13.15 | +52.09% | 1 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $20 | $0.77 | +2,447.02% | 2 | Nov 27, 2019 |
Privia Health Group
Apr 10, 2025
Reiterates: Buy
Price Target: $30
Current: $21.68
Upside: +38.38%
Celestica
Feb 19, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $263.46
Upside: -43.07%
Evolent Health
Jan 10, 2025
Initiates: Buy
Price Target: $15
Current: $2.99
Upside: +401.67%
agilon health
Jan 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.60
Upside: -
Jabil
Dec 19, 2024
Reiterates: Buy
Price Target: $150 → $160
Current: $250.65
Upside: -36.17%
Plexus
Dec 10, 2024
Maintains: Hold
Price Target: $136 → $150
Current: $190.74
Upside: -21.36%
Flex Ltd.
Dec 10, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $63.45
Upside: -24.34%
Hewlett Packard Enterprise Company
Dec 6, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $21.58
Upside: +15.85%
Everpure
Dec 4, 2024
Maintains: Hold
Price Target: $60 → $65
Current: $61.50
Upside: +5.69%
NetApp
Nov 22, 2024
Maintains: Buy
Price Target: $140 → $145
Current: $98.66
Upside: +46.97%
Nov 18, 2024
Initiates: Buy
Price Target: $28
Current: $21.46
Upside: +30.48%
Nov 5, 2024
Maintains: Hold
Price Target: $43 → $38
Current: $34.27
Upside: +10.88%
Aug 13, 2024
Upgrades: Buy
Price Target: $270 → $280
Current: $326.18
Upside: -14.16%
Aug 9, 2024
Maintains: Buy
Price Target: $3 → $2.5
Current: $2.08
Upside: +20.19%
Aug 9, 2024
Maintains: Hold
Price Target: $50 → $55
Current: $59.73
Upside: -7.92%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $24
Current: $90.64
Upside: -73.52%
Jul 17, 2024
Maintains: Buy
Price Target: $250 → $260
Current: $116.16
Upside: +123.83%
Jul 1, 2024
Initiates: Buy
Price Target: $18
Current: $0.50
Upside: +3,500.72%
Jun 13, 2024
Maintains: Hold
Price Target: $112 → $66
Current: $133.92
Upside: -50.72%
May 23, 2024
Maintains: Hold
Price Target: $80 → $90
Current: $75.68
Upside: +18.92%
Apr 3, 2024
Reiterates: Buy
Price Target: $25
Current: $17.23
Upside: +45.10%
Jan 25, 2024
Maintains: Hold
Price Target: $140 → $145
Current: $199.41
Upside: -27.29%
Sep 19, 2023
Maintains: Buy
Price Target: $110 → $120
Current: $153.14
Upside: -21.64%
Apr 19, 2023
Maintains: Buy
Price Target: $285 → $315
Current: $472.16
Upside: -33.29%
Apr 12, 2023
Downgrades: Hold
Price Target: $150
Current: $80.86
Upside: +85.51%
Oct 10, 2022
Maintains: Hold
Price Target: $130 → $105
Current: $140.44
Upside: -25.23%
Aug 11, 2022
Maintains: Hold
Price Target: $24 → $20
Current: $13.15
Upside: +52.09%
Nov 27, 2019
Maintains: Hold
Price Target: $15 → $20
Current: $0.77
Upside: +2,447.02%